Platelet-associated angiogenesis regulating factors: A pharmacological perspective

Canadian Journal of Physiology and Pharmacology

Volumn 90, Issue 6, 2012, Pages 679-688

  Radziwon Balicka, Aneta ^a   Moncada de la Rosa, Cesar ^a   Jurasz, Paul ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS MODULATOR; ANGIOPOIETIN 1; ANGIOSTATIN; BASIC FIBROBLAST GROWTH FACTOR RECEPTOR; CHEMOKINE RECEPTOR CXCR4; ENDOSTATIN; EPIDERMAL GROWTH FACTOR; GELATINASE A; GELATINASE B; HEPARANASE; LIPOPROTEIN A; MATRIX METALLOPROTEINASE; PLASMINOGEN ACTIVATOR INHIBITOR 1; PLATELET DERIVED ENDOTHELIAL CELL GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR; SCATTER FACTOR; SOMATOMEDIN B; SOMATOMEDIN C; SPHINGOSINE 1 PHOSPHATE; STROMAL CELL DERIVED FACTOR 1; THROMBOCYTE FACTOR 4; THROMBOSPONDIN 1; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 4; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN;

ANGIOGENESIS; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW; THROMBOCYTE;

ANGIOGENESIS INDUCING AGENTS; ANGIOGENESIS INHIBITORS; ANIMALS; BLOOD PLATELETS; HUMANS; NEOVASCULARIZATION, PHYSIOLOGIC;

EID: 84870685440     PISSN: 00084212     EISSN: 12057541     Source Type: Journal    
DOI: 10.1139/Y2012-036     Document Type: Review

References (118)

1. Amano, H., Hackett, N.R., Rafii, S., and Crystal, R.G. 2005. Thrombopoietin gene transfer-mediated enhancement of angiogenic responses to acute ischemia. Circ. Res. 97(4): 337-345. doi:10.1161/01.RES.0000179534.17668.f8. PMID:16051888.
2. Amirkhosravi, A., Amaya, M., Siddiqui, F., Biggerstaff, J.P., Meyer, T.V., and Francis, J.L. 1999. Blockade of GpIIb/IIIa inhibits the release of vascular endothelial growth factor (VEGF) from tumor cell-activated platelets and experimental metastasis. Platelets, 10 (5): 285-292. doi:10.1080/09537109975915. PMID:16801104.
3. Assoian, R.K., Komoriya, A., Meyers, C.A., Miller, D.M., and Sporn, M.B. 1983. Transforming growth factor-beta in human platelets. J. Biol. Chem. 258(11): 7155-7160.
4. Bambace, N.M., Levis, J.E., and Holmes, C.E. 2010. The effect of P2Y-mediated platelet activation on the release of VEGF and endostatin from platelets. Platelets, 21(2): 85-93. doi:10.3109/09537100903470298. PMID:20063989.
5. Battinelli, E.M., Markens, B.A., and Italiano, J.E., Jr. 2011. Release of angiogenesis regulatory proteins from platelet alpha granules: modulation of physiologic and pathologic angiogenesis. Blood, 118(5): 1359-1369. doi:10.1182/blood-2011-02-334524. PMID: 21680800.
6. Benedito, R., Roca, C., Sörensen, I., Adams, S., Gossler, A., Fruttiger, M., and Adams, R.H. 2009. The Notch ligands Dll4 and Jagged1 have opposing effects on angiogenesis. Cell, 137(6): 1124-1135. doi:10.1016/j.cell.2009.03.025. PMID:19524514.
7. Betsholtz, C., Lindblom, P., and Gerhardt, H. 2005. Role of pericytes in vascular morphogenesis. In Mechanisms of Angiogenesis Part II. Edited by M. Clauss and G. Breier. Birkhaüser Verlag, Switzerland.
8. Bizzozero, J. 1882. Ueber einen neuen formbestandtheil des blutes und dessen rolle bei der thrombose und blutgerinnung. Virchow's Arch. Path. Anat. 90(2): 261-332. doi:10.1007/BF01931360.
9. Brill, A., Elinav, H., and Varon, D. 2004. Differential role of platelet granular mediators in angiogenesis. Cardiovasc. Res. 63(2): 226-235. doi:10.1016/j.cardiores.2004.04.012. PMID:15249180.
10. Brill, A., Dashevsky, O., Rivo, J., Gozal, Y., and Varon, D. 2005. Platelet-derived microparticles induce angiogenesis and stimulate post-ischemic revascularization. Cardiovasc. Res. 67(1): 30-38. doi:10.1016/j.cardiores.2005.04.007. PMID:15878159.
11. Browder, T., Folkman, J., and Pirie-Shepherd, S. 2000. The hemostatic system as a regulator of angiogenesis. J. Biol. Chem. 275(3): 1521-1524. doi:10.1074/jbc.275.3.1521. PMID: 10636838.
12. Burri, P.H., and Tarek, M.R. 1990. A novel mechanism of capillary growth in the rat pulmonary microcirculation. Anat. Rec. 228(1): 35-45. doi:10.1002/ar.1092280107. PMID:2240600.
13. Burri, P.H., Hlushchuk, R., and Djonov, V. 2004. Intussusceptive angiogenesis: Its emergence, its characteristics, and its significance. Dev. Dyn. 231(3): 474-488. doi:10.1002/dvdy.20184. PMID:15376313.
14. Caine, G.J., Lip, G.Y., and Blann, A.D. 2004. Platelet-derived VEGF, Flt-1, angiopoietin-1 and P-selectin in breast and prostate cancer: further evidence for a role of platelets in tumour angiogenesis. Ann. Med. 36(4): 273-277. doi:10.1080/07853890410026098. PMID:15224653.
15. Carramolino, L., Fuentes, J., Garcia-Andres, C., Azcoitia, V., Riethmacher, D., and Torres, M. 2010. Platelets play an essential role in separating the blood and lymphatic vasculatures during embryonic angiogenesis. Circ. Res. 106(7): 1197-1201. doi:10. 1161/CIRCRESAHA.110.218073. PMID:20203303.
16. Cervi, D., Yip, T.-T., Bhattacharya, N., Podust, V.N., Peterson, J., Abou-Slaybi, A., et al. 2008. Platelet-associated PF-4 as a biomarker of early tumor growth. Blood, 111(3): 1201-1207. doi:10.1182/blood-2007-04-084798. PMID:17914028.
17. Conway, E.M., Collen, D.S., and Carmeliet, P. 2001. Molecular mechanisms of blood vessel growth. Cardiovasc. Res. 49(3): 507-521. doi:10.1016/S0008-6363(00)00281-9. PMID:11166264.
18. Demir, R., Yaba, A., and Huppertz, B. 2010. Vasculogenesis and angiogenesis in the endometrium during menstrual cycle and implantation. Acta Histochem. 112(3): 203-214. doi:10.1016/j. acthis.2009.04.004. PMID:19481785.
19. Deryugina, E.I., and Quigley, J.P. 2010. Pleiotropic roles of matrix metalloproteinases in tumor angiogenesis: contrasting, overlapping and compensatory functions. Biochim. Biophys. Acta, 1803(1): 103-120. doi:10.1016/j.bbamcr.2009.09.017. PMID:19800930.
20. Dirix, L.Y., Vermeulen, P.B., Hubens, G., Benoy, I., Martin, M., De Pooter, C., and Van Oosterom, A.T. 1996. Serum basic fibroblast growth factor and vascular endothelial growth factor and tumour growth kinetics in advanced colorectal cancer. Ann. Oncol. 7(8): 843-848. PMID:8922199.
21. Dong, Z., Kumar, R., Yang, X., and Fidler, I.J. 1997. Macrophagederived metalloelastase is responsible for the generation of angiostatin in Lewis lung carcinoma. Cell, 88(6): 801-810. doi:10.1016/S0092-8674(00)81926-1. PMID:9118223.
22. Dowling, M.R., Josefsson, E.C., Henley, K.J., Hodgkin, P.D., and Kile, B.T. 2010. Platelet senescence is regulated by an internal timer, not damage inflicted by hits. Blood, 116(10): 1776-1778. doi:10.1182/blood-2009-12-259663. PMID:20530288.
23. Doyle, B., and Caplice, N. 2007. Plaque neovascularization and antiangiogenic therapy for atherosclerosis. J. Am. Coll. Cardiol. 49 (21): 2073-2080. doi:10.1016/j.jacc.2007.01.089. PMID:17531655.
24. Eilken, H.M., and Adams, R.H. 2010. Dynamics of endothelial cell behavior in sprouting angiogenesis. Curr. Opin. Cell Biol. 22(5): 617-625. doi:10.1016/j.ceb.2010.08.010. PMID:20817428.
25. Endresen, G.K., and Forre, O. 1985. Studies on the binding of proteins to the human platelet surface: relation to platelet activation. Thromb. Haemost. 53(3): 360-365. PMID:3901392.
26. English, D., Welch, Z., Kovala, A.T., Harvey, K., Volpert, O.V., Brindley, D.N., and Garcia, J.G. 2000. Sphingosine 1-phosphate released from platelets during clotting accounts for the potent endothelial cell chemotactic activity of blood serum and provides a novel link between hemostasis and angiogenesis. FASEB J. 14 (14): 2255-2265. doi:10.1096/fj.00-0134com. PMID:11053247.
27. English, D., Garcia, J.G., and Brindley, D.N. 2001. Platelet-released phospholipids link haemostasis and angiogenesis. Cardiovasc. Res. 49(3): 588-599. doi:10.1016/S0008-6363(00)00230-3. PMID:11166272.
28. Falcone, D.J., Khan, K.M.F., Layne, T., and Fernandes, L. 1998. Macrophage formation of angiostatin during inflammation. A byproduct of the activation of plasminogen. J. Biol. Chem. 273 (47): 31480-31485. doi:10.1074/jbc.273.47.31480. PMID: 9813061.
29. Fam, N.P., Verma, S., Kutryk, M., and Stewart, D.J. 2003. Clinician guide to angiogenesis. Circulation, 108(21): 2613-2618. doi:10. 1161/01.CIR.0000102939.04279.75. PMID:14638526.
30. Feng, W., Madajka, M., Kerr, B.A., Mahabeleshwar, G.H., Whiteheart, S.W., and Byzova, T.V. 2011. A novel role for platelet secretion in angiogenesis: mediating bone marrow-derived cell mobilization and homing. Blood, 117(14): 3893-3902. doi:10. 1182/blood-2010-08-304808. PMID:21224474.
31. Ferrara, N. 2009. Vascular endothelial growth factor. Arterioscler. Thromb. Vasc. Biol. 29(6): 789-791. doi:10.1161/ATVBAHA. 108.179663. PMID:19164810.
32. Folkman, J. 2007. Angiogenesis: an organizing principle for drug discovery? Nat. Rev. Drug Discov. 6(4): 273-286. doi:10.1038/ nrd2115. PMID:17396134.
33. Gately, S., Twardowski, P., Stack, M.S., Patrick, M., Boggio, L., Cundiff, D.L., et al. 1996. Human prostate carcinoma cells express enzymatic activity that converts human plasminogen to the angiogenesis inhibitor, angiostatin. Cancer Res. 56(21): 4887-4890. PMID:8895739.
34. Gately, S., Twardowski, P., Stack, M.S., Cundiff, D.L., Grella, D., Castellino, F.J., et al. 1997. The mechanism of cancer-mediated conversion of plasminogen to the angiogenesis inhibitor angiostatin. Proc. Natl. Acad. Sci. U.S.A. 94(20): 10868-10872. doi:10. 1073/pnas.94.20.10868. PMID:9380726.
35. Gerrard, J.M., Phillips, D.R., Rao, G.H., Plow, E.F., Walz, D.A., Ross, R., et al. 1980. Biochemical studies of two patients with the gray platelet syndrome. Selective deficiency of platelet alpha granules. J. Clin. Invest. 66(1): 102-109. doi:10.1172/JCI109823. PMID:6156948.
36. Girling, J.E., and Rogers, P. 2005. Recent advances in endometrial angiogenesis research. Angiogenesis, 8(2): 89-99. doi:10.1007/ s10456-005-9006-9. PMID:16211359.
37. Giuliari, G.P., Guel, D.A., Cortez, M.A., and Cortez, R.T. 2010. Selective and pan-blockade agents in the anti-angiogenic treatment of proliferative diabetic retinopathy: a literature summary. Can. J. Ophthalmol. 45(5): 501-508. PMID:20648074.
38. Gonzalez, F.J., Rueda, A., Sevilla, I., Alonso, L., Villarreal, V., Torres, E., and Alba, E. 2004. Shift in the balance between circulating thrombospondin-1 and vascular endothelial growth factor in cancer patients: relationship to platelet alpha-granule content and primary activation. Int. J. Biol. Markers, 19(3): 221-228. PMID:15503824.
39. Hanahan, D., and Folkman, J. 1996. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell, 86(3): 353-364. doi:10.1016/S0092-8674(00)80108-7. MID:8756718.
40. Harker, L.A., and Finch, C.A. 1969. Thrombokinetics in man. J. Clin. Invest. 48(6): 963-974. doi:10.1172/JCI106077. PMID:5814231.
41. Heidtmann, H.H., Nettelbeck, D.M., Mingels, A., Jager, R., Welker, H.G., and Kontermann, R.E. 1999. Generation of angiostatin-like fragments from plasminogen by prostate-specific antigen. Br. J. Cancer, 81(8): 1269-1273. doi:10.1038/sj.bjc.6692167. PMID: 10604721.
42. Ho-Tin-Noé, B., Goerge, T., Cifuni, S.M., Duerschmied, D., and Wagner, D.D. 2008. Platelet granule secretion continuously prevents intratumor hemorrhage. Cancer Res. 68(16): 6851-6858. doi:10.1158/0008-5472.CAN-08-0718. PMID:18701510.
43. Huppertz, B., and Peeters, L.L. 2005. Vascular biology in implantation and placentation. Angiogenesis, 8(2): 157-167. doi:10.1007/ s10456-005-9007-8. PMID:16211358.
44. Iba, O., Matsubara, H., Nozawa, Y., Fujiyama, S., Amano, K., Mori, Y., et al. 2002. Angiogenesis by implantation of peripheral blood mononuclear cells and platelets into ischemic limbs. Circulation, 106(15): 2019-2025. doi:10.1161/01.CIR.0000031332.45480.79. PMID:12370229.
45. Italiano, J.E., Jr, Richardson, J.L., Patel-Hett, S., Battinelli, E., Zaslavsky, A., Short, S., et al. 2008. Angiogenesis is regulated by a novel mechanism: pro- and antiangiogenic proteins are organized into separate platelet a granules and differentially released. Blood, 111(3): 1227-1233. doi:10.1182/blood-2007-09-113837. PMID: 17962514.
46. Janowska-Wieczorek, A., Wysoczynski, M., Kijowski, J., Marquez- Curtis, L., Machalinski, B., Ratajczak, J., and Ratajczak, M.Z. 2005. Microvesicles derived from activated platelets induce metastasis and angiogenesis in lung cancer. Int. J. Cancer, 113 (5): 752-760. doi:10.1002/ijc.20657. PMID:15499615.
47. Johnson, S.R., Granton, J.T., and Mehta, S. 2006. Thrombotic arteriopathy and anticoagulation in pulmonary hypertension. Chest, 130(2): 545-552. doi:10.1378/chest.130.2.545. PMID: 16899857.
48. Jurasz, P., Sawicki, G., Duszyk, M., Sawicka, J., Miranda, C., Mayers, I., and Radomski, M.W. 2001. Matrix metalloproteinase 2 in tumor cell-induced platelet aggregation: Regulation by nitric oxide. Cancer Res. 61(1): 376-382. PMID:11196190.
49. Jurasz, P., Chung, A.W.Y., Radomski, A., and Radomski, M.W. 2002. Nonremodeling properties of matrix metalloproteinases: the platelet connection. Circ. Res. 90(10): 1041-1043. doi:10.1161/ 01.RES.0000021398.28936.1D. PMID:12039792.
50. Jurasz, P., Alonso, D., Castro-Blanco, S., Murad, F., and Radomski, M.W. 2003. Generation and role of angiostatin in human platelets. Blood, 102(9): 3217-3223. doi:10.1182/blood-2003-02-0378. PMID:12855585.
51. Jurasz, P., Santos-Martinez, M.J., Radomska, A., and Radomski, M.W. 2006. Generation of platelet angiostatin mediated by urokinase plasminogen activator: effects on angiogenesis. J. Thromb. Haemost. 4(5): 1095-1106. doi:10.1111/j.1538-7836.2006. 01878.x. PMID:16689764.
52. Jurasz, P., Courtman, D., Babaie, S., and Stewart, D.J. 2010a. Role of apoptosis in pulmonary hypertension: From experimental models to clinical trials. Pharmacol. Ther. 126(1): 1-8. doi:10.1016/j. pharmthera.2009.12.006. PMID:20117135.
53. Jurasz, P., Ng, D., Granton, J.T., Courtman, D.W., and Stewart, D.J. 2010b. Elevated platelet angiostatin and circulating endothelial microfragments in idiopathic pulmonary arterial hypertension: a preliminary study. Thromb. Res. 125(1): 53-60. doi:10.1016/j. thromres.2009.04.005. PMID:19427678.
54. Kaplan, D.R., Chao, F.C., Stiles, C.D., Antoniades, H.N., and Scher, C.D. 1979. Platelet alpha granules contain a growth factor for fibroblasts. Blood, 53(6): 1043-1052. PMID:444648.
55. Karey, K.P., and Sirbasku, D. 1989. Human platelet-derived mitogens. II. Subcellular localization of insulin like growth factor I to the alpha-granule and release in response to thrombin. Blood, 74(3): 1093-1100. PMID:2752154.
56. Kim, H.K., Song, K.S., Chung, J.H., Lee, K.R., and Lee, S.N. 2004. Platelet microparticles induce angiogenesis in vitro. Br. J. Haematol. 124(3): 376-384. doi:10.1046/j.1365-2141.2003. 04773.x. PMID:14717787.
57. Kisucka, J., Butterfield, C.E., Duda, D.G., Eichenberger, S.C., Saffaripour, S., Ware, J., et al. 2006. Platelets and platelet adhesion support angiogenesis while preventing excessive hemorrhage. Proc. Natl. Acad. Sci. U.S.A. 103(4): 855-860. doi:10. 1073/pnas.0510412103. PMID:16418262.
58. Klement, G.L., Yip, T.-T., Cassiola, F., Kikuchi, L., Cervi, D., Podust, V., et al. 2009. Platelets actively sequester angiogenesis regulators. Blood, 113(12): 2835-2842. doi:10.1182/blood-2008- 06-159541. PMID:19036702.
59. Klinger, M.H. 1997. Platelets and inflammation. Anat. Embryol. (Berl.), 196(1): 1-11. doi:10.1007/s004290050075. PMID: 9242884.
60. Knighton, D.R., Hunt, T.K., Thakral, K.K., and Goodson, W.H., III. 1982. Role of platelets and fibrin in the healing sequence: an in vivo study of angiogenesis and collagen synthesis. Ann. Surg. 196 (4): 379-388. doi:10.1097/00000658-198210000-00001. PMID: 6181748.
61. Kuhnert, F., Kirshner, J.R., and Thurston, G. 2011. Dll4-Notch signaling as a therapeutic target in tumor angiogenesis. Vasc. Cell, 3(1): 20. doi:10.1186/2045-824X-3-20. PMID:21923938.
62. Langer, H., May, A.E., Daub, K., Heinzmann, U., Lang, P., Schumm, M., et al. 2006. Adherent platelets recruit and induce differentiation of murine embryonic endothelial progenitor cells to mature endothelial cells in vitro. Circ. Res. 98(2): e2-e10. doi:10.1161/01. RES.0000201285.87524.9e. PMID:16373597.
63. Lee, O.-H., Kim, Y.-M., Lee, Y.M., Moon, E.-J., Lee, D.-J., Kim, J.-H., et al. 1999. Sphingosine 1-phosphate induces angiogenesis: Its angiogenic action and signaling mechanism in human umbilical vein endothelial cells. Biochem. Biophys. Res. Commun. 264(3): 743-750. doi:10.1006/bbrc.1999.1586. PMID:10544002.
64. Leeksma, C.H., and Cohen, J.A. 1955. Determination of the life of human blood platelets using labelled diisopropulfluorophosphanate. Nature, 175(4456): 552-553. doi:10.1038/175552b0. PMID: 14370167.
65. Lévy-Toledano, S. 1999. Platelet signal transduction pathways: Could we organize them into a 'hierarchy'? Haemostasis, 29: 4-15. PMID:10494030.
66. Li, J.J., Huang, Y.Q., Basch, R., and Karpatkin, S. 2001. Thrombin induces the release of angiopoietin-1 from platelets. Thromb. Haemost. 86(2): 1597-1598.
67. Lijnen, H.R., Ugwu, F., Bini, A., and Collen, D. 1998. Generation of an angiostatin-like fragment from plasminogen by stromelysin-1 (MMP-3). Biochemistry, 37(14): 4699-4702. doi:10.1021/ bi9731798. PMID:9548733.
68. Ma, L., Elliott, S.N., Cirino, G., Buret, A., Ignarro, L.J., and Wallace, J.L. 2001. Platelets modulate gastric ulcer healing: Role of endostatin and vascular endothelial growth factor release. Proc. Natl. Acad. Sci. U.S.A. 98(11): 6470-6475. doi:10.1073/pnas. 111150798. PMID:11353854.
69. Ma, L., Perini, R., McKnight, W., Dicay, M., Klein, A., Hollenberg, M.D., and Wallace, J.L. 2005. Proteinase-activated receptors 1 and 4 counter-regulate endostatin and VEGF release from human platelets. Proc. Natl. Acad. Sci. U.S.A. 102(1): 216-220. doi:10. 1073/pnas.0406682102. PMID:15615851.
70. Maione, T.E., Gray, G.S., Petro, J., Hunt, A.J., Donner, A.L., Bauer, S.I., et al. 1990. Inhibition of angiogenesis by recombinant human platelet factor-4 and related peptides. Science, 247(4938): 77-79. doi:10.1126/science.1688470. PMID:1688470.
71. Massberg, S., Konrad, I., Schurzinger, K., Lorenz, M., Schneider, S., Zohlnhoefer, D., et al. 2006. Platelets secrete stromal cell-derived factor 1a and recruit bone marrow-derived progenitor cells to arterial thrombi in vivo. J. Exp. Med. 203(5): 1221-1233. doi:10. 1084/jem.20051772. PMID:16618794.
72. Miles, L.A., and Plow, E.F. 1985. Binding and activation of plasminogen on the platelet surface. J. Biol. Chem. 260(7): 4303-4311. PMID:3920216.
73. Mitjavila, M.T., Vinci, G., Villeval, J.L., Kieffer, N., Henri, A., Testa, U., et al. 1988. Human platelet alpha granules contain a nonspecific inhibitor of megakaryocyte colony formation: its relationship to type b transforming growth factor (TGF-b). J. Cell. Physiol. 134(1): 93-100. doi:10.1002/jcp.1041340111. PMID: 3422078.
74. Mohle, R., Green, D., Moore, M.A., Nachman, R.L., and Rafii, S. 1997. Constitutive production and thrombininduced release of vascular endothelial growth factor by human megakaryocytes and platelets. Proc. Natl. Acad. Sci. U. S. A. 94(2): 663-668.
75. Ni, H., Yuen, P.S.T., Papalia, J.M., Trevithick, J.E., Sakai, T., Fassler, R., et al. 2003. Plasma fibronectin promotes thrombus growth and stability in injured arterioles. Proc. Natl. Acad. Sci. U.S.A. 100(5): 2415-2419. doi:10.1073/pnas.2628067100. PMID:12606706.
76. O'Reilly, M.S., Holmgren, L., Shing, Y., Chen, C., Rosenthal, R.A., Moses, M., et al. 1994. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell, 79(2): 315-328. doi:10.1016/0092-8674(94) 90200-3. PMID:7525077.
77. O'Reilly, M.S., Wiederschain, D., Stetler-Stevenson, W.G., Folkman, J., and Moses, M. 1999. Regulation of angiostatin production by matrix metalloproteinase-2 in a model of concomitant resistance. J. Biol. Chem. 274(41): 29568-29571. doi:10.1074/jbc.274.41. 29568. PMID:10506224.
78. Pascaud, M.-A., Griscelli, F., Raoul, W., Marcos, E., Opolon, P., Raffestin, B., et al. 2003. Lung overexpression of angiostatin aggravates pulmonary hypertension in chronically hypoxic mice. Am. J. Respir. Cell Mol. Biol. 29(4): 449-457. doi:10.1165/rcmb. 2002-0120OC. PMID:12714372.
79. Patel-Hett, S., and D'Amore, P.A. 2011. Signal transduction in vasculogenesis and developmental angiogenesis. Int. J. Dev. Biol. 55(4-5): 353-363. doi:10.1387/ijdb.103213sp. PMID:21732275.
80. Patterson, B.C., and Sang, Q.A. 1997. Angiostatin-converting enzyme activities of human matrilysin (MMP-7) and gelatinase B/type IV collagenase (MMP-9). J. Biol. Chem. 272(46): 28823-28825. doi:10.1074/jbc.272.46.28823. PMID:9360944.
81. Pepper, M.S., Ferrara, N., Orci, L., and Montesano, R. 1992. Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitro. Biochem. Biophys. Res. Commun. 189(2): 824-831. doi:10.1016/ 0006-291X(92)92277-5. PMID:1281999.
82. Pesonen, K., Viinikka, L., Myllyla, G., Kiuru, J., and Perheentupa, J. 1989. Characterization of material with epidermal growth factor immunoreactivity in human serum and platelets. J. Clin. Endocrinol. Metab. 68(2): 486-491. doi:10.1210/jcem-68-2-486. PMID:2645310.
83. Peterson, J.E., Zurakowski, D., Italiano, J.E., Jr, Michel, L.V., Fox, L., Klement, G.L., and Folkman, J. 2010. Normal ranges of angiogenesis regulatory proteins in human platelets. Am. J. Hematol. 85(7): 487-493. doi:10.1002/ajh.21732. PMID: 20575035.
84. Phng, L.-K., and Gerhardt, H. 2009. Angiogenesis: A team effort coordinated by Notch. Dev. Cell, 16(2): 196-208. doi:10.1016/j. devcel.2009.01.015. PMID:19217422.
85. Pietramaggiori, G., Scherer, S.S., Cervi, D., Klement, G.L., and Orgill, D.P. 2008. Tumors stimulate platelet delivery of angiogenic factors in vivo: An unexpected benefit. Am. J. Pathol. 173(6): 1609-1616. doi:10.2353/ajpath.2008.080474. PMID:18988799.
86. Prokopi, M., and Mayr, M. 2011. Proteomics: a reality check for putative stem cells. Circ. Res. 108(4): 499-511. doi:10.1161/ CIRCRESAHA.110.226902. PMID:21335432.
87. Prokopi, M., Pula, G., Mayr, U., Devue, C.C., Gallagher, J., Xiao, Q., et al. 2009. Proteomic analysis reveals presence of platelet microparticles in endothelial progenitor cell cultures. Blood, 114 (3): 723-732. doi:10.1182/blood-2009-02-205930. PMID: 19369228.
88. Pula, G., Garonna, E., Dunn, W.B., Hirano, M., Pizzorno, G., Campanella, M., et al. 2010. Paracrine stimulation of endothelial cell motility and angiogenesis by platelet-derived deoxyribose-1- phosphate. Arterioscler. Thromb. Vasc. Biol. 30(12): 2631-2638. doi:10.1161/ATVBAHA.110.215855. PMID:20884872.
89. Radomski, M.W., Palmer, R., and Moncada, S. 1987a. Comparative pharmacology of endothelium-derived relaxing factor, nitric oxide and prostacyclin in platelets. Br. J. Pharmacol. 92(1): 181-187. PMID:3311265.
90. Radomski, M.W., Palmer, R.M.J., and Moncada, S. 1987b. Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet, 330(8567): 1057-1058. doi:10. 1016/S0140-6736(87)91481-4. PMID:2889967.
91. Radomski, M.W., Palmer, R.M., and Moncada, S. 1990. An Larginine/ nitric oxide pathway present in human platelets regulates aggregation. Proc. Natl. Acad. Sci. U.S.A. 87(13): 5193-5197. doi:10.1073/pnas.87.13.5193. PMID:1695013.
92. Radomski, A., Jurasz, P., Sanders, E.J., Overall, C.M., Bigg, H.F., Edwards, D.R., and Radomski, M.W. 2002. Identification, regulation and role of tissue inhibitor of metalloproteinases-4 (TIMP-4) in human platelets. Br. J. Pharmacol. 137(8): 1330-1338. doi:10.1038/sj.bjp.0704936. PMID:12466243.
93. Roberts, D.D. 1996. Regulation of tumor growth and metastasis by thrombospondin-1. FASEB J. 10(10): 1183-1191. PMID: 8751720.
94. Salgado, R., Vermeulen, P.B., Benoy, I., Weytjens, R., Huget, P., Van Marck, E., and Dirix, L.Y. 1999. Platelet number and interleukin-6 correlate with VEGF but not with bFGF serum levels of advanced cancer patients. Br. J. Cancer, 80(5-6): 892-897. doi:10.1038/sj. bjc.6690437. PMID:10360671.
95. Salgado, R., Benoy, I., Bogers, J., Weytjens, R., Vermeulen, P., Dirix, L., and Van Marck, E. 2001. Platelets and vascular endothelial growth factor (VEGF): A morphological and functional study. Angiogenesis, 4(1): 37-43. doi:10.1023/A:1016611230747. PMID:11824377.
96. Salven, P., Orpana, A., and Joensuu, H. 1999. Leukocytes and platelets of patients with cancer contain high levels of vascular endothelial growth factor. Clin. Cancer Res. 5(3): 487-491. PMID: 10100697.
97. Santos-Martínez, M.J., Medina, C., Jurasz, P., and Radomski, M.W. 2008. Role of metalloproteinases in platelet function. Thromb. Res. 121(4): 535-542. doi:10.1016/j.thromres.2007.06.002. PMID:17681591.
98. Savage, B., Almus-Jacobs, F., and Ruggeri, Z.M. 1998. Specific synergy of multiple substrate-receptor interactions in platelet thrombus formation under flow. Cell, 94(5): 657-666. doi:10. 1016/S0092-8674(00)81607-4. PMID:9741630.
99. Sawicki, G., Salas, E., Murat, J., Miszta-Lane, H., and Radomski, M.W. 1997. Release of gelatinase A during platelet activation mediates aggregation. Nature, 386(6625): 616-619. doi:10.1038/ 386616a0. PMID:9121586.
100. Sawicki, G., Sanders, E.J., Salas, E., Wozniak, M., Rodrigo, J., and Radomski, M.W. 1998. Localization and translocation of MMP-2 during aggregation of human platelets. Thromb. Haemost. 80(5): 836-839. PMID:9843163.
101. Scapini, P., Nesi, L., Morini, M., Tanghetti, E., Belleri, M., Noonan, D., et al. 2002. Generation of biologically active angiostatin kringles 1-3 by activated human neutrophils. J. Immunol. 168(11): 5798-5804. PMID:12023382.
102. Schnaper, H.W., Grant, D.S., Stetler-Stevenson, W., Fridman, R., D'Orazi, G., Murphy, A.N., et al. 1993. Type IV collagenase(s) and TIMPs modulate endothelial cell morphogenesis in vitro. J. Cell. Physiol. 156(2): 235-246. doi:10.1002/jcp.1041560204. PMID:8344982.
103. Schor, A.M., Schor, S.L., and Kumar, S. 1979. Importance of a collagen substratum for stimulation of capillary endothelial cell proliferation by tumour angiogenesis factor. Int. J. Cancer, 24(2): 225-234. doi:10.1002/ijc.2910240215. PMID:489164.
104. Semple, J.W., Italiano, J.E., Jr, and Freedman, J. 2011. Platelets and the immune continuum. Nat. Rev. Immunol. 11(4): 264-274. doi:10.1038/nri2956. PMID:21436837.
105. Shai, E., and Varon, D. 2010. Development, cell differentiation, angiogenesis - microparticles and their roles in angiogenesis. Arterioscler. Thromb. Vasc. Biol. 31(1): 10-14. doi:10.1161/ ATVBAHA.109.200980.
106. Soff, G.A. 2000. Angiostatin and angiostatin-related proteins. Cancer Metastasis Rev. 19(1-2): 97-107. doi:10.1023/A:1026525121027. PMID:11191071.
107. Stathakis, P., Fitzgerald, M., Matthias, L.J., Chesterman, C.N., and Hogg, P.J. 1997. Generation of angiostatin by reduction and proteolysis of plasmin. Catalysis by a plasmin reductase secreted by cultured cells. J. Biol. Chem. 272(33): 20641-20645. doi:10. 1074/jbc.272.33.20641. PMID:9252380.
108. Suri, C., Jones, P.F., Patan, S., Bartunkova, S., Maisonpierre, P.C., Davis, S., et al. 1996. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell, 87(7): 1171-1180. doi:10.1016/S0092-8674(00)81813-9. PMID: 8980224.
109. Szekanecz, Z., and Koch, A.E. 2009. Angiogenesis and its targeting in rheumatoid arthritis. Vascul. Pharmacol. 51(1): 1-7. doi:10. 1016/j.vph.2009.02.002. PMID:19217946.
110. Thurston, G., Noguera-Troise, I., and Yancopoulos, G.D. 2007. The delta paradox: DLL4 blockade leads to more tumour vessels but less tumour growth. Nat. Rev. Cancer, 7(5): 327-331. doi:10.1038/ nrc2130. PMID:17457300.
111. Trikha, M., Zhou, Z., Timar, J., Raso, E., Kennel, M., Emmell, E., and Nakada, M.T. 2002. Multiple roles for platelet GPIIb/IIIa and alphavbeta3 integrins in tumor growth, angiogenesis, and metastasis. Cancer Res. 62(10): 2824-2833. PMID:12019160.
112. Verheul, H.M., Hoekman, K., Luykx-de Bakker, S., Eekman, C.A., Folman, C.C., Broxterman, H.J., and Pinedo, H.M. 1997. Platelet: transporter of vascular endothelial growth factor. Clin. Cancer Res. 3(12): 2187-2190. PMID:9815613.
113. Verheul, H.M.W., Hoekman, K., Lupu, F., Broxterman, H.J., van der Valk, P., Kakkar, A.K., and Pinedo, H.M. 2000. Platelet and coagulation activation with vascular endothelial growth factor generation in soft tissue sarcomas. Clin. Cancer Res. 6(1): 166-171. PMID:10656446.
114. Vieira-de-Abreu, A., Campbell, R.A., Weyrich, A.S., and Zimmerman, G.A. 2011. Platelets: versatile effector cells in hemostasis, inflammation, and the immune continuum. Semin. Immunopathol. 34(1): 5-30. PMID:21818701.
115. Wartiovaara, U., Salven, P., Mikkola, H., Lassila, R., Kaukonen, J., Joukov, V., et al. 1998. Peripheral blood platelets express VEGF-C and VEGF which are released during platelet activation. Thromb. Haemost. 80(1): 171-175. PMID:9684805.
116. Westphal, J.R., Van't Hullenaar, R., Geurts-Moespot, A., Sweep, F.C. J.G., Verheijen, J.H., Bussemakers, M.M.G., et al. 2000. Angiostatin generation by human tumor cell lines: Involvement of plasminogen activators. Int. J. Cancer, 86(6): 760-767. doi:10. 1002/(SICI)1097-0215(20000615)86:6<760::AID-IJC2>3.0. CO;2-4. PMID:10842188.
117. Yatomi, Y., Ruan, F., Hakomori, S., and Igarashi, Y. 1995. Sphingosine-1-phosphate: a platelet-activating sphingolipid released from agonist-stimulated human platelets. Blood, 86(1): 193-202. PMID:7795224.
118. Zaslavsky, A., Baek, K.-H., Lynch, R.C., Short, S., Grillo, J., Folkman, J., et al. 2010. Platelet-derived thrombospondin-1 (TSP- 1) is a critical negative regulator and potential biomarker of angiogenesis. Blood, 115(22): 4605-4613. doi:10.1182/blood- 2009-09-242065. PMID:20086246.